GSE239844 6 V 5 CRIZOTINIB HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE239844 6 V 5 CRIZOTINIB HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE239844 6 V 5 CRIZOTINIB HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE239844 6 V 5 CRIZOTINIB HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE239844 6 V 5 CRIZOTINIB HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

DExD-box helicase 52

Gene

SRC kinase signaling inhibitor 1

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

ribosomal protein SA 2

Gene

dehydrogenase/reductase X-linked

Gene

LYNX1-SLURP2 readthrough

Gene

PHD finger protein 12

Gene

trimethyllysine hydroxylase, epsilon

Gene

mitotic arrest deficient 1 like 1

Gene

leucine rich repeat and coiled-coil centrosomal protein 1

  • Gene

    DExD-box helicase 52


  • Gene

    SRC kinase signaling inhibitor 1


  • Gene

    colony stimulating factor 2 receptor subunit alpha


  • Gene

    ribosomal protein SA 2


  • Gene

    dehydrogenase/reductase X-linked


  • Gene

    LYNX1-SLURP2 readthrough


  • Gene

    PHD finger protein 12


  • Gene

    trimethyllysine hydroxylase, epsilon


  • Gene

    mitotic arrest deficient 1 like 1


  • Gene

    leucine rich repeat and coiled-coil centrosomal protein 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.